Hepatocyte Piezo1 regulates glycogen metabolism via the FGF21-STAT3 pathway
Cellular and Molecular Life Sciences · 2025
DOI: 10.1007/s00018-025-05921-4 ↗At a glance
Journal article in Cellular and Molecular Life Sciences, 2025. Written by Tian Tao and 7 co-authors. Institution: Department of Physiology, School of Medicine, Jinan University, 601 Huangpu Avenue West, Tianhe District, Guangzhou, Guangdong, 510632, China. Major MEDLINE topics: STAT3 Transcription Factor, Fibroblast Growth Factors, Ion Channels, Hepatocytes. 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China.
Abstract (original language)
The metabolism of glycogen in the liver plays a crucial role in regulating blood glucose levels. Previous studies have underscored the critical involvement of Piezo1 in glucose metabolism. However, the role of Piezo1 in hepatic glycogen metabolism remain unexplored. We induced liver-specific deletion of Piezo1 in Piezo1fl/fl mice using Cre adenovirus via tail vein injection. Compared to Piezo1fl/fl treated with GFP adenovirus, those treated with AAV-Cre exhibited impaired glucose tolerance, elevated GYS2 and PYGL levels, and decreased FGF21 levels, implicating inhibition of the STAT3 signaling pathway. Furthermore, mice with hepatocyte-specific Piezo1 deletion (Alb-Piezo1-/-) on a high-fat diet experienced exacerbated blood glucose levels, decreased hepatic FGF21 production, and enhanced PYGL expression and activity. These effects were alleviated by PF-05231023, an FGF21 analog. Additionally, intraperitoneal injection of Yoda1, a Piezo1 agonist, raised FGF21 levels, activating the STAT3 pathway and suppressing PYGL activity, thereby improving glucose tolerance. In vitro studies showed that knockdown of Piezo1 or Stat3 increased PYGL expression. Conversely, activation of Piezo1 led to decreased PYGL expression. Our study reveals a previously unexplored regulatory mechanism of glycogen metabolism by Piezo1 in liver cells, offering new insights into diabetes treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Physiology, School of Medicine, Jinan University, 601 Huangpu Avenue West, Tianhe District, Guangzhou, Guangdong, 510632, China.
- School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, China.
- Biotherapy Center, Cell-gene Therapy Translational Medicine Research Center, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510630, China. chenh567@mail.sysu.edu.cn.
- Department of Physiology, School of Medicine, Jinan University, 601 Huangpu Avenue West, Tianhe District, Guangzhou, Guangdong, 510632, China. xugeyangliang@163.com.
- Key Laboratory of Viral Pathogenesis & Infection Prevention and Control, Jinan University, Ministry of Education, Guangzhou, Guangdong, 510632, China. xugeyangliang@163.com.
Funding
- National Natural Science Foundation of China
Cite
APA
Tao, T., Yang, K., Li, Z., Zhang, M., Zhang, Z., Guo, J., Chen, H., & Xu, G. (2025). Hepatocyte Piezo1 regulates glycogen metabolism via the FGF21-STAT3 pathway. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-025-05921-4
Vancouver
Tao T, Yang K, Li Z, Zhang M, Zhang Z, Guo J, et al. Hepatocyte Piezo1 regulates glycogen metabolism via the FGF21-STAT3 pathway. Cellular and Molecular Life Sciences. 2025. doi:10.1007/s00018-025-05921-4
BibTeX
@article{Tao2025,
author = {Tao, Tian and Yang, Ke and Li, Zhenming and Zhang, Mengyuan and Zhang, Zhejiao and Guo, Jinghui and Chen, Hui and Xu, Geyang},
title = {Hepatocyte Piezo1 regulates glycogen metabolism via the FGF21-STAT3 pathway},
journal = {Cellular and Molecular Life Sciences},
year = {2025},
doi = {10.1007/s00018-025-05921-4}
}
EUVIMED